Clinical trial

LEAP2 on Postprandial Glucose Metabolism and Food Intake

NCT04621409

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-11-17

PhaseEARLY_PHASE1

Study timeline

Study start (actual)2020-11-17Date precision: day

Registry last updated2021-05-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Interventions

Liver-enriched antimicrobial peptide 2BIOLOGICAL

PlaceboBIOLOGICAL

Sponsors & collaborators

University Hospital, Gentofte, Copenhagenlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04621409 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.